Prenatal Paracetamol Exposure and Offspring ADHD Risk: A Narrative Review of Evidence, Plausibility, and Implications
Quality in Sport · 13.08.2026 · 68 · 74297
DOI: 10.12775/qs.2026.68.74297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 13.08.2026. Verfasst von Anna Olborska und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Paracetamol is the most commonly used analgesic and antipyretic during pregnancy. Concurrently, attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition. Recent evidence has raised concerns regarding the potential impact of prenatal paracetamol exposure on offspring ADHD risk.
Objective
To examine the current evidence linking prenatal paracetamol exposure to ADHD, evaluate biological plausibility, and assess clinical and public health implications.
Methods
This narrative review synthesized findings from prospective cohort studies, case–control studies, and meta-analyses published mostly within the past decade and indexed in PubMed, PMC, Lancet.
Results
Several observational cohort studies and meta-analyses report modest associations between prenatal paracetamol exposure and increased risk of ADHD. Meta-analyses and umbrella reviews highlight moderate heterogeneity and substantial vulnerability to residual confounding, particularly confounding by indication and shared familial factors. Importantly, large nationwide cohort studies incorporating sibling-controlled analyses suggest that previously observed relationships may largely reflect genetic, environmental, or maternal health-related confounding rather than causal effects.
Conclusion
Recent reviews emphasize that while observed associations warrant a precautionary approach, the available evidence from observational studies cannot establish a causal link between typical prenatal acetaminophen (paracetamol) use and ADHD diagnosis in children. As such it is still present as first-line treatment, when clinically indicated, used at the lowest effective dose and shortest duration according to regulatory agencies such as EMA.
Zitieren
APA
Olborska, A., Wrochna, B. M., Brzozowska, A., Stondzik, G., Garbacz, A. I., Kosiorek, P., Radziwonka, A., Majszyk, T. J., Głuski, J., Borowiecka, P. A., Węglarz, A., & Niezgoda, A. (2026). Prenatal Paracetamol Exposure and Offspring ADHD Risk: A Narrative Review of Evidence, Plausibility, and Implications. Quality in Sport, 68, 74297. https://doi.org/10.12775/qs.2026.68.74297
Vancouver
Olborska A, Wrochna BM, Brzozowska A, Stondzik G, Garbacz AI, Kosiorek P, et al. Prenatal Paracetamol Exposure and Offspring ADHD Risk: A Narrative Review of Evidence, Plausibility, and Implications. Quality in Sport. 2026;68:74297. doi:10.12775/qs.2026.68.74297
BibTeX
@article{Olborska2026,
author = {Olborska, Anna and Wrochna, Bartłomiej Maciej and Brzozowska, Agnieszka and Stondzik, Gabriela and Garbacz, Anna Izabela and Kosiorek, Paweł and Radziwonka, Agnieszka and Majszyk, Tomasz Julian and Głuski, Jacek and Borowiecka, Patrycja Anna and Węglarz, Aleksandra and Niezgoda, Ada},
title = {Prenatal Paracetamol Exposure and Offspring ADHD Risk: A Narrative Review of Evidence, Plausibility, and Implications},
journal = {Quality in Sport},
year = {2026},
volume = {68},
pages = {74297},
doi = {10.12775/qs.2026.68.74297}
}
EUVIMED